Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease.

Kistler AD, Mischak H, Poster D, Dakna M, Wüthrich RP, Serra AL.

Kidney Int. 2009 Jul;76(1):89-96. doi: 10.1038/ki.2009.93. Epub 2009 Apr 1.

2.

Clinical and laboratory markers of autosomal dominant polycystic kidney disease (ADPKD) progression: an overview.

Corradi V, Gastaldon F, Virzì GM, Caprara C, Martino F, Ronco C.

Minerva Med. 2015 Feb;106(1):53-64. Epub 2014 Oct 10. Review.

PMID:
25300895
3.

Emergent early markers of renal progression in autosomal-dominant polycystic kidney disease patients: implications for prevention and treatment.

Helal I, Reed B, Schrier RW.

Am J Nephrol. 2012;36(2):162-7. doi: 10.1159/000341263. Epub 2012 Jul 26. Review.

PMID:
22846584
4.

Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.

Alam A, Dahl NK, Lipschutz JH, Rossetti S, Smith P, Sapir D, Weinstein J, McFarlane P, Bichet DG.

Am J Kidney Dis. 2015 Oct;66(4):564-76. doi: 10.1053/j.ajkd.2015.01.030. Epub 2015 May 7. Review.

PMID:
25960302
5.

Hypertension in children with autosomal dominant polycystic kidney disease (ADPKD).

Cadnapaphornchai MA.

Curr Hypertens Rev. 2013 Feb;9(1):21-6. Review.

PMID:
23971640
6.

Urinary proteomics in the assessment of chronic kidney disease.

Mullen W, Delles C, Mischak H; EuroKUP COST action.

Curr Opin Nephrol Hypertens. 2011 Nov;20(6):654-61. doi: 10.1097/MNH.0b013e32834b7ffa. Review.

PMID:
21885967

Supplemental Content

Support Center